| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP And General Counsel
1 company
Lynch Brian Joseph is a SVP And General Counsel at MADRIGAL PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 32 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And General Counsel | Sale+OE | 2,800 | $221.89 | $621,294.00 | -5.7% | +4.9% | +35.5% | |
| Nov 30, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And General Counsel | Sale+OE | 7,000 | $201.50 | $1,410,480.00 | -8.0% | +25.1% | +61.4% | |
| Jan 3, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And General Counsel | Sale+OE | 13,000 | $282.92 | $3,677,976.60 | -19.5% | -12.8% | -25.7% | |
| Dec 23, 2022 | MDGL Madrigal Pharmaceuticals, Inc. | SVP And General Counsel | Sale+OE | 7,000 | $274.18 | $1,919,230.69 | -15.5% | -15.2% | -14.1% |